I write in strong opposition to major funding cuts at the National Institutes of Health and National Science Foundation. Research at both institutions and projects funded by them across the ...

Diffuse Large B-Cell Lymphoma Companies are involved in targeted therapeutics development with respective active and inactive ...

Researchers at The Tisch Cancer Institute at Mount Sinai have uncovered a major reason why some colorectal cancers (CRC) ...

Survivors of blood or marrow transplants (BMT) face a significantly higher risk of developing cutaneous malignant neoplasms, including basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and ...

“With this latest expansion, Vetscan Imagyst becomes the only commercially available veterinary diagnostic tool of its kind ...

Zoetis has announced that Vetscan Imagyst, its multi-purpose diagnostic tool, is getting 'AI Masses', a new capability which uses AI to analyse ...

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “A case report of donor cell–derived ...

Share and Cite: Hinz, B. and Kenyon, J. (2025) Getting to a Diagnosis: A Rare Case of TFE3 Translocation Renal Cell Carcinoma ...

With 44,000 new diagnoses each year, non-small cell lung cancer is the second most frequent neoplasm in Italy after breast cancer. When the disease is in an advanced stage and surgery is no longer ...

Heather Wakelee, MD, Stanford University, discusses the pros and cons of different durations of immunotherapy in non-small cell lung cancer (NSCLC) and the future outlook for patient-specific care.

As pet owners, we dread the day our companions show signs of illness, but a vet has explained everything you need to know.